Preference in Dogs of Two Oral Endectoparasiticide Formulations: NexGard Spectra<sup>®</sup> (Afoxolaner and Milbemycin Oxime) and Credelio<sup>®</sup> Plus (Lotilaner and Milbemycin Oxime)

Journals Menu

Follow SCIRP

ISSN Print: 2165-3356
ISSN Online: 2165-3364
www.scirp.org/journal/ojvm
E-mail: ojvm@scirp.org

Citations h5-index & Ranking*

"Preference in Dogs of Two Oral Endectoparasiticide Formulations: NexGard Spectra^® (Afoxolaner and Milbemycin Oxime) and Credelio^® Plus (Lotilaner and Milbemycin Oxime)"
written by Nadège Perier, Douglas S. Carithers, William Russel Everett, Phrutsamon Wongnak, Karine Chalvet-Monfray, Frederic Beugnet,
published by Open Journal of Veterinary Medicine, Vol.11 No.8, 2021

has been cited by the following article(s):

No relevant information.

[1]	Efficacy of an oral combination of moxidectin, afoxolaner, and pyrantel pamoate for the prevention of heartworm disease in dogs Research in Veterinary Science, 2023 DOI:10.1016/j.rvsc.2023.104957

[2]	Efficacy of an oral combination of moxidectin, afoxolaner, and pyrantel pamoate for the prevention of heartworm disease in dogs Research in Veterinary Science, 2023 DOI:10.1016/j.rvsc.2023.104957

[3]	Efficacy of an oral formulation of afoxolaner and milbemycin oxime against Tunga penetrans in naturally infected dogs Parasites & Vectors, 2023 DOI:10.1186/s13071-023-06063-x

[4]	WITHDRAWN: Efficacy for the prevention of heartworm disease in dogs of an oral combination of moxidectin, afoxolaner, and pyrantel pamoate Research in Veterinary Science, 2022 DOI:10.1016/j.rvsc.2022.11.012

[5]	WITHDRAWN: Efficacy for the prevention of heartworm disease in dogs of an oral combination of moxidectin, afoxolaner, and pyrantel pamoate Research in Veterinary Science, 2022 DOI:10.1016/j.rvsc.2022.11.012

Follow SCIRP